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Background
The existence of B cells with a suppressive function,
namely regulatory B cells (Bregs), has been demon-
strated in a number of murine models of autoimmunity
in the last decade. Adoptive transfer of Bregs has been
shown to inhibit the development of several autoim-
mune diseases via the release of Interleukin-10 (IL-10).
Aim
To ascertain the role of IL-10 secreting Bregs during the
induction and progression of experimental autoimmune
disease in mice.Then to use this information to identify
an equivalent subset in man and assess the impact of
Bregs on inflammatory responses and disease severity.
Materials and methods
We generated chimeric mice that lack IL-10 specifically
in their B cells and used this model to investigate the role
of endogenous B cell- derived IL-10 during inflammatory
arthritis. Moreover, we have identified and assessed the
role of Bregs in healthy individuals as well as patients
with rheumatological disorders.
Results
We have recently investigated the mechanisms utilized by
endogenous Breg at the cellular level in an experimental
model of arthritis and shown that the IL-10 produced by
Bregs is important in the maintenance of regulatory T
cells (Tregs) whilst suppressing Th1 and Th17 responses.
Indeed chimeric mice specifically lacking IL-10 producing
B cells (IL-10-/-B cell) developed an exacerbated arthritis,
displayed reduced absolute numbers of FoxP3+ Tregs, and
a marked increase in inflammatory Th1 and Th17 cells
compared to chimeric wild type B cell mice. In addition
we extended our results from experimental models of
arthritis to humans and identified an equivalent popula-
tion of Breg that produce IL-10, inhibit CD4+T effector
responses and convert effector CD4+T cells into regula-
tory T cells.
Conclusions
Our work has demonstrated the importance of Bregs in
controlling inflammatory responses and preventing auto-
immunity in both experimental arthritis in mice [1,2] and
patients with rheumatological disorders [3]. This presenta-
tion reports the function of this pivotal B cell subset and
describes Bregs in the context of healthy individuals as
well as in patients with systemic lupus erythematosus and
rheumatoid arthritis.The impact of altered cellular func-
tion within the Breg compartment on disease outcome
will be also discussed [4,5].
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